Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Disc Medicine, Inc

Clinical trials sponsored by Disc Medicine, Inc, explained in plain language.

Trials to join now! 5 Not yet finished but already full! 2 Completed 2

New drug bitopertin offers hope for sunlight pain relief in rare blood disorders

Disease control ENROLLING_BY_INVITATION

This long-term study tests the safety and effectiveness of bitopertin (DISC-1459) in people with erythropoietic protoporphyria (EPP) or X-linked protoporphyria (XLP), rare conditions that cause severe pain from sunlight exposure. About 230 participants who previously took bitoper…

Phase: PHASE2, PHASE3 • Sponsor: Disc Medicine, Inc • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC
New pill could let Sun-Sensitive patients enjoy the outdoors

Disease control Ongoing

This Phase 3 trial tests whether bitopertin, a daily pill, can help people with erythropoietic protoporphyria (EPP) or X-linked protoporphyria (XLP) spend more time in sunlight without pain. About 183 participants aged 12 and older will take bitopertin or a placebo for 6 months. …

Phase: PHASE3 • Sponsor: Disc Medicine, Inc • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC